fda bpc-157 safety risks compounding BREAKING NEWS! The FDA's Pharmacy Advisory Committee has voted in support of four highly anticipated peptides—a major step toward broader patient access through licensed compounding pharmacies. Swipe to see the peptides Should the FDA ease restrictions

Research shows specific peptides can modulate immune responses, reduce inflammatory cytokine production, and promote tissue healing in ways that conventional treatments cannot achieve

Semaglutide (Ozempic, Wegovy, Rybelsus) is a prescription GLP-1 medication used for weight loss and weight management, type 2 diabetes treatment, or to reduce the risk of chronic kidney disease and major cardiovascular events in certain patients with type 2 diabetes

For CrossFit athletes dealing with systemic inflammation from chronic high-intensity training, this has a compounding benefit -- it does not just help the specific injury, it reduces the overall inflammatory load that slows recovery across the board

It is framed as supporting repair conditions that are often weak

It also promotes angiogenesis in muscle injury models, speeding recovery from trauma